About Kumiko Endo
Form D filings for Med2Lab from 2023 to 2024 list Kumiko Endo as executive officer and director.
Kumiko Endo first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Kumiko Endo in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Kumiko Endo works with at each company, as listed on that company's latest Form D.
Med2Lab, Inc. · Form D/A, Jun 6, 2024
KN
Kiat Neo
Executive officer and director
BT
Bao Truong
Chief Executive Officer and director